CHICAGO, IL – January 26, 2023 – Sheridan is pleased to announce the successful closing of 27 transactions in 2022. This past year also saw the last platform investment in Fund II with the closing of RSA and activation of SCP Fund III with our investment in ADVI. Thank you to all who supported our growth this year. We are appreciative of your partnership, and we look forward to more success together in 2023.
Firm & Fund Activity
• Closed two new platform investments
• Completed 25 add-on acquisitions
• Exited investments in SpendMend and Dermatologists of Central States
• Hired five new team members
Sector: Outsourced Medical Equipment Repair & Maintenance
RSA provides recurring repair and preventive maintenance services, spare and replacement parts, equipment sales, installations and removals, and other services to operators of linear accelerators (“LINACs”) and other capital medical equipment. RSA is a patient-focused, quality-driven independent service organization (“ISO”) that serves over 100 hospitals, medical centers, private cancer centers, universities, veterinary clinics urology clinics, GPOs, and asset managers.
Sector: Pharma Services
ADVI Health solves complicated problems in healthcare with data-informed commercialization, market access, and policy expertise. Comprised of a seasoned group of industry experts from the policy, payer, and life sciences sectors, ADVI provides strategic support to health and science innovators around the world, guiding clients from diligence and discovery through commercialization and proactively identifying opportunities to improve access and reimbursement and accelerate time to revenue and growth.
All of our portfolio companies are actively seeking add-on investments. Over the past year, we completed 25 tuck-ins across our portfolio companies.
SimiTree provides tech-enabled specialty revenue cycle management (RCM), coding, professional services, and talent management resources for post-acute and behavioral health organizations. Recent acquisitions solidly established SimiTree as a comprehensive service provider to the post-acute industry through its combination with Infinity Behavioral Health Services and its subsequent acquisition of both Afia and GreenpointMed, expanding its reach within mental health RCM.
Tarrytown Expocare, a national long-term care pharmacy that serves individuals with intellectual and developmental disabilities (“IDD”), completed the acquisition of RxHealth and Heartland Homecare, and now provides services in 13 states. Tarrytown is looking to acquire IDD pharmacies or IDD beds from retail or other long-term care pharmacies nationwide.
Sheridan Capital Partners continues to invest in talent, adding five new hires across the firm in 2022 to supplement the investment team, operations group, and business development team. These hires include investment team member Brian McGregor who joined as Vice President after completing his MBA at Northwestern University’s Kellogg School of Management and Brent Blankenship, who will support the firm’s business development efforts.
If you are an intermediary, operating executive, or business owner interested in partnering with Sheridan, please reach out to Alexandra Kier.
Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, bringing strategic resources to accelerate growth, build enduring value, and achieve strong results.